PCM
SGEN

Pentwater Capital Management’s Seagen Inc. Common Stock SGEN Stock Holding History

Pentwater Capital Management’s Portfolio SGEN Stock Details SGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-12,880,000
Closed -$2.73B – 141
2023
Q3 		$2.73B Buy
12,880,000
+3,250,500
+34% +$649M 14.69% 2
2023
Q2 		$1.85B Buy
9,629,500
+7,874,500
+449% +$1.56B 12.81% 1
2023
Q1 		$355M Buy
+1,755,000
New +$281M 3.44% 5

Other funds holding SGEN

SCM
Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
FBC
Fairfield, Bush & Co Darien, Connecticut $203M AUM 38.37% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
SAG
Spotlight Asset Group Oakbrook Terrace, Illinois $143M AUM 20.66% 1-Year Est. Return

Pentwater Capital Management's SGEN Position: Q4 2023 in Review

Pentwater Capital Management sold out of Seagen Inc. Common Stock (SGEN) in Q4 2023, closing a stake of 12,880,000 shares — an estimated $2.73B sold.

Pentwater Capital Management first reported a position in SGEN in Q1 2023 and held it in 3 quarters. The position peaked at $2.73B in Q3 2023. 6 funds tracked by Wall St. Rank hold SGEN as of Q4 2023.

  • Pentwater Capital Management reported no remaining Seagen Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Pentwater Capital Management sold 12,880,000 Seagen Inc. Common Stock shares in Q4 2023, an estimated $2.73B.
  • Pentwater Capital Management first reported a position in Seagen Inc. Common Stock in Q1 2023 and held it in 3 quarters.
  • Pentwater Capital Management's Seagen Inc. Common Stock position peaked at $2.73B in Q3 2023.
  • 6 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q4 2023.

Based on Pentwater Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.